Sign in

NCT03609580RecruitingPhase 1/2

Post-operative Urinary Retention (POUR) Following Thoracic Surgery

Source: ClinicalTrials.gov · Last updated 11 Jun 2026

Brief summary (registry, in English)

Inability to urinate a common complication that happens to many patients after a surgery, especially in men over 60 years of age who undergo surgery on their chest. Urinary retention is uncomfortable, increases anxiety, increases hospital length of stay, and leads to more procedures such as putting in a bladder catheter (Foley). This is uncomfortable, and can lead to bleeding, infection, damage to the urethra and/or bladder and bladder spasm. The goal of this study is to attempt to prevent inability to urinate by giving patients a medication called Flomax (Tamusolin) every day beginning a week before surgery. That medication relaxes the prostate. It's approved by the Food and Drug Administration (FDA) to improve urinary flow in those with enlarged prostates. It is also commonly used in patients with bladder problems due to inability to urinate who have required a Foley.

Status (registry)
Recruiting
Phase (registry)
Phase 1/2
Study type
Interventional
Enrollment
127 (estimated)
First submitted
12 Jul 2018
Start date
7 May 2018
Primary completion date
30 Mar 2027
Lead sponsor
Hackensack Meridian Health
Diseases
Lung cancer
NCT number
NCT03609580

What you commit to

  • Study type: Interventional · Phase 1/2
  • Planned participants: 127
  • From 7 May 2018 to the primary completion date, 30 Mar 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Allergy to Flomax or sulfa drugs
  • Known diagnosis of congestive heart failure and valvular heart disease
  • History of prostate surgery (prostatectomy, trans-urethral resection)

Other

  • Using Flomax already
  • Current use of alpha blockers or alpha agonists
  • Resting systolic blood pressure \<100
  • Orthostatic hypotension of \>20mm Hg (millimeters of mercury) Systolic and/or 10mm Hg diastolic pressure from sitting to standing (after 2 minutes of standing) as measured at the time of consent

Who the study is looking for

  • Males
  • ≥50 years old Planned surgical procedure of a minimally invasive thoracic surgical procedure (wedge resection, segmentectomy, lobectomy, pleural biopsy, or pleurodesis) Surgery scheduled more than 3 days from the time of consent

Age in the registry: 50 years to - · Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Michael Spallone
Coordinator of this site? Confirm its status
HackensackUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.